Pancreatic Cancer Research

ResearcherErciyes UniversityActive in the last 2 years

Ahmet İnal

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-5917-3729; OpenAlex author ID A5053704237.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Dextromethorphan Enhances Apoptosis and Suppresses EMT in PANC-1 Pancreatic Cancer Cells: Synergistic Effects with Gemcitabine. Last author DOI 10.3390/ijms26178151↗
  2. Indomethacin prevents TGF-β-induced epithelial-to-mesenchymal transition in pancreatic cancer cells; evidence by Raman spectroscopy. Co-author DOI 10.1016/j.saa.2022.121493↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Gulsah Medet · 1 shared paper, 2025
  2. Zeynep Ciftci · 1 shared paper, 2022
  3. Gülay Sezer · 1 shared paper, 2022

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.